Karlan B - Search Results

1

Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers.

Singh K, Lester J, Karlan B, Bresee C, Geva T, Gordon O. Singh K, et al. Among authors: karlan b. Am J Obstet Gynecol. 2013 Apr;208(4):329.e1-6. doi: 10.1016/j.ajog.2013.01.026. Epub 2013 Jan 17. Am J Obstet Gynecol. 2013. PMID: 23333547

2

Advanced-stage ovarian carcinoma presenting during infertility evaluation.

Karlan BY, Marrs R, Lagasse LD. Karlan BY, et al. Am J Obstet Gynecol. 1994 Nov;171(5):1377-8. doi: 10.1016/0002-9378(94)90164-3. Am J Obstet Gynecol. 1994. PMID: 7977550

3

Surgical intensive care unit care after ovarian cancer surgery: an analysis of indications.

Amir M, Shabot MM, Karlan BY. Amir M, et al. Among authors: karlan by. Am J Obstet Gynecol. 1997 Jun;176(6):1389-93. doi: 10.1016/s0002-9378(97)70366-1. Am J Obstet Gynecol. 1997. PMID: 9215205

4

Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening.

Karlan BY, Baldwin RL, Lopez-Luevanos E, Raffel LJ, Barbuto D, Narod S, Platt LD. Karlan BY, et al. Am J Obstet Gynecol. 1999 Apr;180(4):917-28. doi: 10.1016/s0002-9378(99)70663-0. Am J Obstet Gynecol. 1999. PMID: 10203660

5

Improved survival in women with BRCA-associated ovarian carcinoma.

Cass I, Baldwin RL, Varkey T, Moslehi R, Narod SA, Karlan BY. Cass I, et al. Cancer. 2003 May 1;97(9):2187-95. doi: 10.1002/cncr.11310. Cancer. 2003. PMID: 12712470 Free article.

6

Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures.

Li AJ, Baldwin RL, Karlan BY. Li AJ, et al. Am J Obstet Gynecol. 2003 Jul;189(1):22-7. doi: 10.1067/mob.2003.328. Am J Obstet Gynecol. 2003. PMID: 12861133

7

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.

Liede A, Karlan BY, Narod SA. Liede A, et al. J Clin Oncol. 2004 Feb 15;22(4):735-42. doi: 10.1200/JCO.2004.05.055. J Clin Oncol. 2004. PMID: 14966099 Review.

8

Coexisting ovarian malignancy in young women with endometrial cancer.

Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Walsh C, et al. Among authors: karlan b. Obstet Gynecol. 2005 Oct;106(4):693-9. doi: 10.1097/01.AOG.0000172423.64995.6f. Obstet Gynecol. 2005. PMID: 16199623

9

Ovarian preservation in stage I low-grade endometrial stromal sarcomas.

Li AJ, Giuntoli RL 2nd, Drake R, Byun SY, Rojas F, Barbuto D, Klipfel N, Edmonds P, Miller DS, Karlan BY. Li AJ, et al. Obstet Gynecol. 2005 Dec;106(6):1304-8. doi: 10.1097/01.AOG.0000185511.91694.1e. Obstet Gynecol. 2005. PMID: 16319256

10

BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?

Cass I, Holschneider C, Datta N, Barbuto D, Walts AE, Karlan BY. Cass I, et al. Obstet Gynecol. 2005 Dec;106(6):1327-34. doi: 10.1097/01.AOG.0000187892.78392.3f. Obstet Gynecol. 2005. PMID: 16319259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

583 results

Search Page

Filters